Antidepressant discontinuation syndrome
≥3 of the following within days of stopping/reducing an antidepressant (after ≥1 month use): FINISH symptoms — flu-like; insomnia; nausea; imbalance; sensory disturbances; hyperarousal/anxiety
≥3 of the following within days of stopping/reducing an antidepressant (after ≥1 month use): FINISH symptoms — flu-like; insomnia; nausea; imbalance; sensory disturbances; hyperarousal/anxiety
Preoccupation with having or acquiring a serious illness
Uninterrupted period of illness including a major mood episode (MDE or manic) concurrent with Schizophrenia Criterion A symptoms
Both multiple motor tics AND ≥1 vocal tic present at some time during the illness, though not necessarily simultaneously
≥3 of 12 catatonia symptoms: stupor; catalepsy; waxy flexibility; mutism; negativism; posturing; mannerism; stereotypy; agitation; grimacing; echolalia; echopraxia
Evidence by polysomnography of ≥5 central apnoeas per hour of sleep
Disturbance of attention (reduced ability to direct, focus, sustain, shift attention) and awareness (reduced orientation to environment)
Falsification of physical or psychological signs or symptoms, or induction of injury or disease, associated with identified deception in self (imposed on self) or in another person (imposed on another)
Excessive anxiety/worry about multiple events/activities, more days than not for ≥6 months
Criteria met for major or mild NCD
Intoxication: recent opioid use; Withdrawal: cessation/reduction after heavy prolonged use, or administration of opioid antagonist
Symptoms characteristic of a somatic symptom/related disorder causing clinically significant distress/impairment
≥2 of: delusions; hallucinations; disorganised speech; grossly disorganised/catatonic behaviour; negative symptoms — ≥1 must be delusions, hallucinations, or disorganised speech
≥1 somatic symptom that is distressing or results in significant disruption of daily life